Paul Horstmeier, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 13,142 shares at $44.47 ($599K) on 2021-03-05, disclosed to the SEC on 2021-03-09.
Open-market sale of $599k HCAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.47 | 1,712 | $76K | 12.7% |
| 2 | $44.47 | 1,712 | $76K | 12.7% |
| 3 | $45.73 | 3,147 | $144K | 24.0% |
| 4 | $45.73 | 3,147 | $144K | 24.0% |
| 5 | $46.27 | 1,712 | $79K | 13.2% |
| 6 | $46.27 | 1,712 |
| $79K |
| 13.2% |
| Total | $45.54 avg | 13,142 | $599K | 100% |
| Filing → |
| HCAT | SELL | 2022-03-11 | $587K | — | Filing → |
| HCAT | SELL | 2022-02-09 | $626K | — | Filing → |
| HCAT | SELL | 2022-01-06 | $791K | — | Filing → |